Not Signed In - Evotec Initiates Second Phase II Clinical Trial With Insomnia Drug EVT 201
Sat, 18 Nov 2006 08:00 AM EST
... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX 30) announced today the initiation of a second Phase II study with EVT 201 under a US IND. This randomised, multi-centre, double-blind study is a parallel design study with two doses of EVT 201 and placebo in 135 elderly patients with chronic primary insomnia and day-time sleepiness. [click link for full article] ...
Related Topics
- Clinical Trials
- Insomnia
- Tarceva
- Pharmacology
- Psychopharmacology
- Thallium
- Bevacizumab Injection
- Trastuzumab
- Drug Safety
- Prescription Drugs
- Drug Side Effects
- Nystatin and Triamcinolone
- Drug Abuse
- Drug Information
- Prescription Drug Abuse
- Prescription Drugs Abuse
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Clinical Growth Charts
- Depression
email this page
print this page
bookmark this page
feedback on this page
